We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Scans Can Detect Chemical Imbalance in Brain

By MedImaging International staff writers
Posted on 22 Dec 2016
Magnetic resonance imaging (MRI) can be used to measure the higher levels of oxidative stress present in patients with schizophrenia, according to a new study.

Researchers at Harvard Medical School (HMS; Boston, MA, USA) and McLean Hospital (Belmont, MA, USA) used a novel magnetic resonance spectroscopy technique to identify oxidative stress in 21 patients with chronic schizophrenia by measuring the brain concentrations of two molecules, nicotinamide adenine dinucleotide (NAD+) and nicotinamide adenine dinucleotide hydrogen (NADH), that give a readout of how well the brain is able to buffer out excessive oxidants.

The researchers found a 53% elevation in NADH in the chronic schizophrenia patients, as compared to healthy individuals of similar age. A similar degree of NADH elevation was also seen in newly diagnosed schizophrenia, suggesting that oxidation imbalance is present even in the early stages of illness. Modest NADH increases were also seen in bipolar disorder, which shares some genetic and clinical overlap with schizophrenia. The study was presented at the American College of Neuropsychopharmacology annual meeting, held during December 2016 in Hollywood (FL, USA).

“Intensive energy demands on brain cells lead to accumulation of highly reactive oxygen species, such as free radicals and hydrogen peroxide. However, measuring this process in the living human brain has remained challenging,” said lead author Fei Du, PhD, an assistant professor of psychiatry at HMS. “In addition to offering new insights into the biology of schizophrenia, this finding also provides a potential way to test the effectiveness of new interventions.”

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to comprehend reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices, reduced social engagement and emotional expression, and a lack of motivation. People with schizophrenia often have additional mental health problems such as anxiety disorders, major depressive illness, or substance use disorders. Schizophrenia does not imply a split or multiple personality disorder, conditions with which it is often confused in public perception.

Related Links:
Harvard Medical School
McLean Hospital
High-Precision QA Tool
DEXA Phantom
Computed Tomography System
Aquilion ONE / INSIGHT Edition
X-ray Diagnostic System
FDX Visionary-A
Medical Radiographic X-Ray Machine
TR30N HF

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.